Breast Cancer Staging: How Doctors Assess Your Stage and What It Means for Treatment

Breast Cancer Staging: How Doctors Assess Your Stage and What It Means for Treatment

After a breast cancer diagnosis, staging clarifies how far the disease has progressed. It informs treatment plans, helps gauge prognosis, and provides a common language for patients and clinicians.

How Staging Works

The most widely used system is the American Joint Committee on Cancer (AJCC) TNM classification, often referred to as the TNM system:

• T – Tumor size and extent of the primary tumor.
• N – Spread to nearby lymph nodes.
• M – Presence of distant metastasis.

In 2018, the AJCC incorporated biomarkers into staging. These include:

• Hormone receptor status (estrogen, progesterone).
• HER2 status.
• Grade (how cancer cells differ from normal breast cells).
• Oncotype DX score – a genomic test predicting likelihood of recurrence.

After evaluating TNM and biomarkers, the cancer is assigned an overall stage from 0 to IV.

Stage 0 – Ductal Carcinoma In Situ (DCIS)

Non‑invasive cancer confined to the milk ducts; no invasion into surrounding breast tissue.

Stage I – Early Invasive Cancer

Invasive cancer that has not yet spread to lymph nodes.

Stage IA

• Tumor ≤ 2 cm.
• No lymph node involvement.

Stage IB

• Tumor ≤ 2 cm or no detectable tumor.
• Small clusters of cancer cells in 1–3 nearby lymph nodes.

Stage II – Moderately Advanced Invasive Cancer

Stage IIA

• No detectable tumor or tumor <2 cm.
• Up to 3 affected lymph nodes.
• Alternatively, a tumor 2–5 cm with no lymph node involvement.

Stage IIB

• Tumor 2–5 cm.
• Small clusters in lymph nodes or up to 3 affected nodes.
• Or tumor >5 cm without lymph node spread.

Stage III – Locally Advanced Cancer

Stage IIIA

• Any tumor size.
• 4–9 affected lymph nodes.
• Or tumor >5 cm with up to 3 affected nodes.

Stage IIIB

• Any tumor size.
• Direct extension to chest wall or skin.
• Up to 9 affected lymph nodes or nodes near the collarbone.

Stage IIIC

• Any tumor size.
• Extension to chest wall or skin.
• ≥10 affected lymph nodes or involvement of nodes under the arm, near the breastbone, or around the collarbone.

Stage IV – Metastatic Breast Cancer

Cancer has spread beyond the breast and regional nodes to distant organs.

A 2017 study found that among stage IV patients, bone metastases were most common (65.1%), followed by lung (31.4%), liver (26%), and brain (8.8%). About one‑third had multi‑site disease.

Symptoms vary with metastatic sites but may include bone pain, shortness of breath, jaundice, or neurological deficits.

Survival Outlook by Stage

The National Cancer Institute’s SEER database reports five‑year relative survival rates that differ by stage:

• Localized (stage 0–I): ~99%
• Regional (stage II–III): ~91%
• Distant (stage IV): ~27%

These figures illustrate the critical impact of early detection and treatment.

What Staging Means for You

Your stage informs both treatment options—such as surgery, radiation, chemotherapy, endocrine therapy, and targeted agents—and the likely prognosis. Discuss your specific stage, biomarkers, and genomic scores with your multidisciplinary team to tailor a plan that best suits your needs.

Ask questions, review your pathology report, and stay informed about emerging therapies that may improve outcomes even in advanced stages.